Page 1704 - Clinical Small Animal Internal Medicine

1642 Index

vacuolar hepatology 665, 665 septic shock 423 idioventricular rhythm 200, 203
VetBooks.ir vaginal tumors 1318–1319 vasopressin (VP) see antidiuretic surgical approaches to thoracic
signalment 199
valvular heart disease 250
vacuolar hepatopathy 677–678
disease 326, 329
VAKI see Veterinary Acute
hormone
Kidney Injury vasopressors 410, 427 treatment 200–204, 203
validity see external validity; internal VCLE see vesicular cutaneous lupus ventricular fibrillation 200,
validity erythematosus 202–204, 202, 204
valvular heart disease 245–252 VEGF see vascular endothelial growth ventricular premature
canine degenerative myxomatous factor depolarizations/contractions
mitral valve disease 245–250, venomous snake bites 459–465 199–200, 202
247–248, 247 antivenin therapy 462–464 ventricular fibrillation 200,
classification/staging of diagnosis 461–462 202–204, 202
MMVD 247 epidemiology 460–461 ventricular premature depolarizations/
diagnosis 247–248, 247, etiology/pathophysiology 459–460 contractions (VPC) 199–200, 202
251, 251 first aid 462 ventricular septal defect (VSD) 231,
epidemiology 246, 250 history and clinical signs 461 232, 237, 241–243
etiology/pathophysiology neuromuscular junction ventricular synchrony 177
245–246, 250 diseases 808 ventricular tachycardia (VT) 200, 202,
history and clinical signs prognosis 464, 465 204, 413–414, 419
246–247, 250–251 signalment 461 vertebral heart score (VHS)
infectious endocarditis 250–251 snake bite severity score 464, 465 128–130, 130, 131
prognosis 248, 248, 251 treatment 462–464 vesicles 1384
treatment 248–250, 251 venous admixture 383–384, 389 vesicular cutaneous lupus
valvular interstitial cells (VIC) 245 ventilation erythematosus (VCLE)
vancomycin‐resistant enterococci cardiopulmonary resuscitation 367, 1426–1427, 1426
(VRE) 1059–1060 371 vestibular ataxia 732
VAP see ventilator‐associated critical care setting 350 vestibular disease 789–794
pneumonia head trauma 756 anatomy/physiology 789
vascular endothelial growth factor respiratory monitoring in critical anomalous/congenital causes
(VEGF) 539, 1208–1209 care 376–377, 376 790, 792
vascular occlusive disorders 821–822 see also mechanical ventilation central vestibular disease
vascular ring anomalies (VRA) ventilation–perfusion (V–Q) mismatch 789–790, 792–794
congenital heart disease 234 acute respiratory failure 385–386, differentiating peripheral from
esophageal disorders 562 385, 389 central disease 789–790
gastrointestinal imaging pulmonary thromboembolism 320 etiology 790–794
476, 477 respiratory monitoring in critical idiopathic causes 791
vasculature care 377–378 infectious causes 791
cutaneous manifestations of systemic surgical approaches to thoracic inflammatory causes 791–794
disease 1487 disease 325–326 peripheral vestibular disease
forebrain disorders 785–788 ventilator‐associated pneumonia 790–792
hepatobiliary disease 660, 664, (VAP) 400 vascular causes 792–793
670–673, 671–673 ventilator‐induced lung injury Veterinary Acute Kidney Injury (VAKI)
neuroendocrinology 41 (VILI) 390, 401 staging scheme 1091
skeletal development and ventricular arrhythmias veterinary bedside lung ultrasound
homeostasis 1513–1514, (VA) 199–204 examination (VetBLUE)
1516–1517 acute therapy 203–204 292–293, 293
vestibular disease 792–793 canine myocardial disease VHS see vertebral heart score
vasculitis 1433, 1434, 1487 255–256, 260–265 VIC see valvular interstitial cells
vasodilation chronic therapy 204 videotoscopy 1473, 1473, 1478, 1478
cardiogenic shock 418 diagnosis 200, 201–203 VILI see ventilator‐induced lung injury
heart failure 186, 187, 188–189, etiology/pathophysiology 199 viral infections
193–194, 195, 196–197 feline myocardial disease cutaneous manifestations of systemic
hypothermia 433 270–271, 273 disease 1484–1485, 1484
pulmonary thromboembolism 320 history and clinical signs 199–200 laboratory diagnosis 843–844